Minitran 15 (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Minitran 15, is a nitrate presented as a 15 mg (24 h) transdermal patch for cutaneous (transdermal) use. It treats angina pectoris and is used in patients with chronic stable angina.

GNH USA supplies Minitran 15 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minitran 15, a nitrate anti‑anginal agent, is used in the management of coronary artery disease.

Prophylaxis of angina pectoris: provides continuous nitrate delivery to prevent angina attacks. Treatment of chronic stable angina: reduces frequency and severity of angina episodes. Adjunct therapy during exercise testing: stabilises myocardial oxygen demand and limits exercise‑induced angina.

Common Side Effects: - Headache: throbbing pain often occurring shortly after patch application. - Flushing: warm sensation and reddening of the skin. - Dizziness: light‑headed feeling, especially when standing quickly. - Skin irritation at the patch site: erythema or itching.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Syncope: sudden loss of consciousness. - Allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention.

Before initiating therapy, consider the following precautions: - Assess cardiovascular status: evaluate blood pressure and heart rate. - Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Monitor for tolerance development: consider a daily nitrate‑free interval. - Educate patient on patch rotation: change site daily to reduce skin irritation. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Minitran 15 may interact with several medicines. Review the following:

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): can cause severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive blood‑pressure lowering effect.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors): may enhance blood‑pressure reduction. - Alcohol: can increase vasodilatory effects and dizziness. - Azole antifungals (e.g., ketoconazole): may raise nitrate plasma concentrations.